comparemela.com
  1. Home
  2. Live Updates
  3. Edmund Hainisch - Breaking News

Latest Breaking News On - Edmund hainisch - Page 1 : comparemela.com

Innovative flu-based vaccine against equine sarcoids shows promise

The vaccine should render successfully treated horses immune to future infections by the bovine papillomaviruses that cause sarcoids.

Edmund hainischSabine brandtChristoph jindraUniversity of veterinary medicineBacillus calmette guKarl landsteiner universityHealth sciencesVeterinary medicineEquine sarcoidsFrom early approachesCreative commons license

Potential vaccines against papillomaviruses in horses show much promise - review

Papillomaviruses play a role in sarcoids and squamous cell carcinomas in horses.

Reinhard kirnbauerChristoph jindraEdmund hainischSabine brandtVeterinary universityMedical universityLike particlesCreative commons license

Equine Sarcoids - visible success with delNS-based immunotherapy leads the way towards cancer therapy in humans

/PRNewswire/ Scientists from the Viennese biotech company BlueSky Immunotherapies GmbH (Ltd.) have used their viral vector platform delNS to treat sarcoids.

Thomas musterEdmund hainischBluesky immunotherapies gmbBluesky immunotherapiesSabine brandtIsoldem bergmannBluesky immunotherapies gmbh ltdUniversity of veterinary medicine viennaVeterinary medicine viennaMariahilfer straBluesky immunotherapies gmbhHealth care amp hospitalsStem scienceClinical trials amp medical discoveries

BlueSky Immunotherapies GmbH: Equine Sarcoids - visible success with delNS-based immunotherapy leads the way towards cancer therapy in humans

VIENNA, Dec. 10, 2021 /PRNewswire/ Scientists from the Viennese biotech company BlueSky Immunotherapies GmbH (Ltd.) have used their viral vector platform delNS to treat sarcoids in horses.

Kostenloser wertpapierhandelThomas musterEdmund hainischBluesky immunotherapies gmbBluesky immunotherapiesSabine brandtIsoldem bergmannBluesky immunotherapies gmbh ltdUniversity of veterinary medicine viennaVeterinary medicine viennaMariahilfer stra

Equine Sarcoids - visible success with delNS-based immunotherapy leads the way towards cancer therapy in humans

/PRNewswire/ Scientists from the Viennese biotech company BlueSky Immunotherapies GmbH (Ltd.) have used their viral vector platform delNS to treat sarcoids.

Thomas musterEdmund hainischBluesky immunotherapies gmbBluesky immunotherapiesSabine brandtIsoldem bergmannBluesky immunotherapies gmbh ltdUniversity of veterinary medicine viennaVeterinary medicine viennaMariahilfer straBluesky immunotherapies gmbh

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.